STAMBPL1 and neoplasm: To assess the role of STAMBPL1 in the efficacy of immunotherapy in renal cancer, we constructed subcutaneous tumor‐bearing mice models using control Renca cells or STAMBPL1 KD Renca cells and those mice were administrated the anti‐PD‐1 antibody (αPD‐1) (Figure 6K).